Results 281 to 290 of about 2,740,951 (332)
Some of the next articles are maybe not open access.
2018
Beginning with the definition of biotechnology, this chapter provides a systematic review of the industry’s growth and transformation over almost half a century, both in the United States and around the world. The scientific, technological, regulatory, economic, and financial developments contributing to its current state are discussed in detail.
Stuart O. Schweitzer, Z. John Lu
openaire +1 more source
Beginning with the definition of biotechnology, this chapter provides a systematic review of the industry’s growth and transformation over almost half a century, both in the United States and around the world. The scientific, technological, regulatory, economic, and financial developments contributing to its current state are discussed in detail.
Stuart O. Schweitzer, Z. John Lu
openaire +1 more source
Insect gut as a bioresource for potential enzymes - an unexploited area for industrial biotechnology
Biocatalysis and Agricultural Biotechnology, 2019Recently, insect gut protease has gained great interest in the field of food and industrial biotechnology due to their invisible characteristics and also their ability to act as an alternative source for microbial protease.
M. Kannan +5 more
semanticscholar +1 more source
Thermostable Enzymes for Industrial Biotechnology
Advances in Enzyme Technology, 2019Enzyme-based processes promise a sustainable and environmentally-friendly solution to the pollution that results from industrial technologies. Thermozymes are extremely temperature-stable biocatalysts that broaden the application horizon of enzymes ...
Sunny Sharma +4 more
semanticscholar +1 more source
Journal of Pharmacy Practice, 1998
Growth and change are the hallmarks of the developing biotechnology industry. Since the first approval of a biological product in 1982, over 40 biologicals, many of them medical breakthroughs, have been brought to market. The majority of biotechnology companies focus on developing human therapeutic agents, but about 25 percent of biotechnology ...
openaire +1 more source
Growth and change are the hallmarks of the developing biotechnology industry. Since the first approval of a biological product in 1982, over 40 biologicals, many of them medical breakthroughs, have been brought to market. The majority of biotechnology companies focus on developing human therapeutic agents, but about 25 percent of biotechnology ...
openaire +1 more source
Microfluidic tools toward industrial biotechnology
Biotechnology Progress, 2016Microfluidics is a technology that operates with small amounts of fluids and makes possible the investigation of cells, enzymes, and biomolecules and encapsulation of biocatalysts in a greater variety of conditions than permitted using conventional methods. This review discusses technological possibilities that can be applied in the field of industrial
Aline F, Oliveira +3 more
openaire +2 more sources
Biotechnology industrial competitiveness
Technology in Society, 1986Abstract The author reviews several key Congressional and Administration reports addressing federal research, regulatory and fiscal policies that directly affect high-technology industries, such as the biotechnology industry. In order to stimulate research by private industry, Congress has tried to lower the costs of private R&D through a combination
openaire +1 more source
Unconventional β-Glucosidases: A Promising Biocatalyst for Industrial Biotechnology
Applied Biochemistry and Biotechnology, 2021Ravish Godse +3 more
semanticscholar +1 more source
2006
Abstract Biotechnology represents perhaps the most innovative and dynamic segment of the pharmaceutical industry, which is already known as being innovative and dynamic. The growth of biotechnology firms is not a simple story. The geographic location of firms, the ways in which they started, and the means by which they mature all ...
openaire +1 more source
Abstract Biotechnology represents perhaps the most innovative and dynamic segment of the pharmaceutical industry, which is already known as being innovative and dynamic. The growth of biotechnology firms is not a simple story. The geographic location of firms, the ways in which they started, and the means by which they mature all ...
openaire +1 more source
1985
The biological revolution underscores the success of the federal government’s commitment to the support of basic research: the billions for health research through the National Institute of Health (NIH) in the 1950s and 1960s directly led to the discovery of recombinant DNA technology. As Dr.
openaire +1 more source
The biological revolution underscores the success of the federal government’s commitment to the support of basic research: the billions for health research through the National Institute of Health (NIH) in the 1950s and 1960s directly led to the discovery of recombinant DNA technology. As Dr.
openaire +1 more source
Biotechnology and the Pharmaceutical Industry
Cancer Investigation, 1993(1993). Biotechnology and the Pharmaceutical Industry. Cancer Investigation: Vol. 11, No. 4, pp. 451-457.
openaire +2 more sources